Using this approach, our group discovered that impinging upon STAT3 signaling in combination with Ref-1/APE1 signaling dramatically affects the viability and migratory ability of pancreatic cancer cell lines (Fig. 3 and ref. 13). The gene discussed is STAT3; the disease is pancreatic neoplasm.